Osteonecrosis of the femoral head (ONFH) means death of the bone of the head of the femur, In the past, the treatment for advanced ONFH was frequently “wait until it’s bad enough to replace the hip joint.” Early treatment was an attempt to manage pain while slowing the progression of bone destruction.
Treatment for ONFH without a Hip Replacement
Recent medical innovations have created more effective orthopedic options for treating ONFH, which result in decreased pain, require a shorter recuperation period, and are less expensive. Stem cell tissue from the patient’s body is at the center of new treatment for osteonecrosis of the femoral head.
The Institute of Regenerative & Molecular Orthopaedics or IRMO has combined the implantation of the patient’s stem cell tissue with other innovative treatment options to provide a uniquely effective and safe method of treatment. Mesenchymal stem cell tissue is obtained in an office procedure using local anesthetic by a board certified orthopedic surgeon. Stem cells injected into the body, along with human growth hormone and platelet rich plasma, stimulate repair and regrowth of bone tissue. Over-the-counter supplements also provide key nutrients to support recovery.
The exact course of treatment is dependent upon the stage of ONFH. As an orthopedic practice, IRMO is committed to continuing research in treatment of osteonecrosis. Hyperbaric therapy, for example, has been in clinical use since the 1960s and recent research reveals potential to improve treatment of ONFH. Hip replacement is no longer the only option for patients suffering with the pain and loss of mobility associated with osteonecrosis.